A University of California, Riverside preclinical study is shedding light on a long-observed but poorly understood phenomenon: chronic cannabis users tend to have lower body weight and a reduced risk of developing type 2 diabetes, despite the drug’s well-known tendency to increase appetite. Nicholas DiPatrizio A team led by Nicholas V. DiPatrizio, a professor of biomedical sciences at the UCR School of Medicine, set out to investigate this apparent paradox. While cannabis is commonly associated with increased […]

Read more

Shaina Alexandria, PhD, assistant professor of Preventive Medicine in the Division of Biostatistics and Informatics, was a co-author of the study published in Nature Medicine.  A time-restricted eating program — consuming all meals between 1 p.m. and 7 p.m. without tracking calorie intake — promoted greater weight loss in women with polycystic ovary syndrome (PCOS) than no intervention, according to a randomized controlled trial published in Nature Medicine.   The results suggest time-restricted eating can promote weight loss and potentially alleviate symptoms in women with PCOS, an endocrine disorder that affects nearly 1 in 5 women of childbearing […]

Read more

Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (World Health Organization, 2025). World Obesity Atlas 2024. https://www.worldobesity.org/news/world-obesity-atlas-2024 (World Obesity Federation, 2024). Boutari, C. & Mantzoros, C. S. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism 133, 155217 (2022). Article  CAS  PubMed  PubMed Central  Google Scholar  Imes, C. C. & Burke, L. E. The obesity epidemic: the USA […]

Read more

(Oona Zenda/KFF Health News) A professional in-home caregiver lost her coverage for Zepbound. She soon realized getting it back was not straightforward. “I was like: ‘What am I going to do? Hopefully I can just continue keeping this weight off.’” — Deborah Finley, 50, of Lodi, California Deborah Finley, 50, of Lodi, California, said her weight started to worry her during the early days of covid. That’s when she noticed a lot of the people who were […]

Read more

Eli Lilly on Thursday said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering significant weight loss across doses.  The results bring Lilly one step closer to filing for approval of the weekly injection, called retatrutide, which works differently from existing shots and pills from both Lilly and Novo Nordisk. It also appears to be more effective than those options. The highest dose of retatrutide helped patients lose 28.3% of their weight — […]

Read more

Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as “breakthrough” drugs in 2023 — and their popularity has soared since.  More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/2026​​1​, while around 2.5 million people each month accessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of the Digital Clinical Excellence (DiCE) network of primary care digital health providers.  According to a YouGov poll commissioned by the National Pharmacy Association, an estimated […]

Read more

CROWLEY, Texas – A former North Texas principal is facing felony drug charges. Investigators said Gerardo Moreno Mendez was illegally selling weight loss drugs to teachers when he worked at Crowley ISD. Gerardo Moreno Mendez’s Arrest What we know: According to court documents, the alleged crime happened back in January. Moreno Mendez reportedly sold the prescription weight loss drug Tirzepatide, commonly referred to as a GLP-1, to at least three teachers and staff members in the Crowley […]

Read more

Share on PinterestA new biweekly GLP-1 injection has been shown to significantly reduce blood sugar in a clinical trial. Image Credit: Hannes P Albert/picture alliance via Getty Images A new GLP-1 medication demonstrated efficacy in reducing blood sugar in people with type 2 diabetes in a phase 2b clinical trial. Bofanglutide is a biweekly (once every 2 weeks) injection compared to once-weekly shots like Ozempic and Wegovy. The new biweekly GLP-1 also led to weight loss and […]

Read more

“I’m now at a point where I’m going to buy even more clothes,” says Hayley Grice, 50, from Shropshire, who has dropped seven sizes after starting on the GLP-1 weight loss jab Mounjaro two years ago. “I’m very happy with my physique right now.” Grice, the financial director of a business she set up with her husband, tried gastric bypass surgery in 2009, but put most of the weight back on, and had been between UK dress […]

Read more

Greta sits in her car and sings to the camera: “Greta, reta, bo, beta, banana, fana, fo, feta, fee, fi, fo, reta, Greta. Trutide.” Cait posts before-and-after pictures—“40 pounds down” and “#jesusloves”—following up with a reading of her favorite psalm. From his bedroom, Gabriel addresses his 462,000 followers about his adventures with low-dose reta—“I think it’s something that everyone should be doing”—and adds a link in his bio to his peptide supplier. These teenagers and twentysomethings are […]

Read more